Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Receives Consensus Recommendation of "Buy" from Brokerages

Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report) has been assigned an average rating of "Buy" from the eight ratings firms that are covering the company, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation, two have given a buy recommendation and three have given a strong buy recommendation to the company.

A number of research firms have recently issued reports on RBGLY. Barclays downgraded shares of Reckitt Benckiser Group from an "overweight" rating to an "equal weight" rating in a research report on Tuesday, February 4th. Royal Bank of Canada reiterated an "outperform" rating on shares of Reckitt Benckiser Group in a research report on Friday, March 7th.

Reckitt Benckiser Group Stock Up 1.4%

OTCMKTS:RBGLY traded up $0.19 during mid-day trading on Friday, reaching $13.66. The stock had a trading volume of 207,116 shares, compared to its average volume of 385,246. The company has a debt-to-equity ratio of 0.97, a current ratio of 0.69 and a quick ratio of 0.47. Reckitt Benckiser Group has a twelve month low of $10.43 and a twelve month high of $14.10. The business has a 50 day simple moving average of $13.04 and a 200 day simple moving average of $12.82.

Reckitt Benckiser Group Increases Dividend

The business also recently disclosed a dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 11th will be given a dividend of $0.2909 per share. This is an increase from Reckitt Benckiser Group's previous dividend of $0.19. The ex-dividend date of this dividend is Friday, April 11th.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.